Contract Pharma Magazine
January/February 2023
-
CDMOs in the Spotlight: Investing in Themselves
Successful strategy for growth, CDMO opportunities, and balancing specialization.02.06.23
-
Extrusion-Spheronization in OSD Manufacturing
How extrusion-spheronization excels delivering controlled and modified release dose forms.02.06.23
-
Modernizing Therapeutic Cell Production
Science-based innovation for manufacturing high quality cells challenges dogma and terminology.02.06.23
-
Don’t Panic! A Toxicologist’s View on Proceeding After a Clinical Hold
Step back, reassess your program, and move forward with a solid strategy in place.02.06.23
-
Digital Transformation in Pharma
Digital technologies are bringing people and processes together across the pharmaceutical industry. Good transformation management is the key to success.02.06.23
-
Fill-Finish in Cell & Gene Therapy
Mitigating the inherent risks of cell and gene therapy processing with automation.02.06.23
-
Early-Stage Biotechs: What’s Essential and What’s Not
Using contract services to “balance” the capabilities needed now and those that will prepare for the future.02.06.23
-
Five Insights to Maximize Customer-Centric Acquisition Growth
Keeping it all together for the sake of multi-dimensional value.02.06.23
-
Challenges in API Technical Transfer
A look at key process risks and analytical parameters that must be identified to ensure a successful technology transfer.02.06.23
-
Managing Your CareerLetting Your Guard DownDiscussing weaknesses can sometimes be a positive.01.31.23
-
Sponsored ContentCROs at the High Table of Drug DiscoveryOffshoring reaches an inflection point as CROs turn risk-sharing partners in discovery research. This is the first of a nine-part series.01.30.23
-
Back PageBeat the Supply Chain BacklogHow accelerated project timelines are key to meeting demand in the pharmaceutical industry.02.06.23
